Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Ovarian Neoplasms 2Multiple Myeloma 2Fallopian Tube Neoplasms 2Unspecified Childhood Solid Tumor, Protocol Specific 1Pancreatic Neoplasms 1Melanoma 1Anemia 1

Interventions

Irinotecan 3Cyclophosphamide 3temsirolimus 2Sirolimus 2sargramostim 1reolysin 1irofulven 1etoposide phosphate 1cixutumumab 1aflibercept 1Tirapazamine 1Temozolomide 1Methylprednisolone 1Melphalan 1Mass Spectrometry 1Immunologic Techniques 1Genetic Testing 1Gene Expression Profiling 1Gemcitabine 1Gefitinib 1Flow Cytometry 1Filgrastim 1Cyclosporine 1Cord Blood Stem Cell Transplantation 1Cisplatin 1Carboplatin 1Busulfan 1Bortezomib 1Bevacizumab 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Unspecified Childhood Solid Tumor, Protocol Specific × reolysin × Clear all
NCT01240538 2014-05-13

Viral Therapy in Treating Young Patients With Relapsed or Refractory Solid Tumors

National Cancer Institute (NCI)

Phase 1 Completed
26 enrolled
Other solid neoplasm

Unspecified Childhood Solid Tumor, Protocol Specific

Data powered by HemOnc (CC BY 4.0) Colophon âš¡